Propiedades magnetoelásticas de aleaciones feromagnéticas con memoria de forma

Las aleaciones metamagnéticas pertenecen a las aleaciones ferromagnéticas con memoria de forma (FSMA). Estas aleaciones presentan los efectos de memoria de forma de las propias FSMA y otras características como la magnetorresistencia, los efectos magnetocalóricos y magnetocalóricos inversos que las hacen de gran interés para diversas aplicaciones. Estos efectos se debe a la caída de la imanación entre la fase austenita ferromagnética y la martensita durante la transición estructural. El carácter magnético de la fase austenita es conocido debido a varios experimentos que se han llevado a cabo, pero en el caso de la fase martensita está aún sin concretar habiendo varias opciones posibles. Es de vital importancia conocer el comportamiento magnético de la fase martensita para aplicaciones futuras de las aleaciones metamagnéticas. En este trabajo se ha estudiado la aleación Ni50Mn36In14 (T2B) la cual ha sido sometida a medidas magnéticas con el fin de acercarnos más al conocimiento del carácter magnético de estas aleaciones y concretar la temperatura de Curie mediante un estudio de los exponentes críticos de los “Arrott Plot generalizados”. Mediante el estudio de los exponentes críticos se obtienen estos resultados: Austenita: β=0.2 y γ=1.5. TCA=300.7 K Martensita: β=0.2 y γ=1.5. TCM=202 K II

Impact of depressive symptoms on subjective well-being: the importance of patient-reported outcomes in schizophrenia

Objective: The subjective experience of psychotic patients toward treatment is a key factor in medication adherence, quality of life, and clinical outcome. The aim of this study was to assess the subjective well-being in patients with schizophrenia and to examine its relationship with the presence and severity of depressive symptoms. Methods: A multicenter, cross-sectional study was conducted with clinically stable outpatients diagnosed with schizophrenia. The Subjective Well-Being under Neuroleptic Scale - short version (SWN-K) and the Calgary Depression Scale for Schizophrenia (CDSS) were used to gather information on well-being and the presence and severity of depressive symptoms, respectively. Spearman's rank correlation was used to assess the associations between the SWN-K total score, its five subscales, and the CDSS total score. Discriminative validity was evaluated against that criterion by analysing the area under the curve (AUC). Results: Ninety-seven patients were included in the study. Mean age was 35 years (standard deviation = 10) and 72% were male. Both the total SWN-K scale and its five subscales correlated inversely and significantly with the CDSS total score (P < 0.0001). The highest correlation was observed for the total SWN-K (Spearman's rank order correlation [ rho] = -0.59), being the other correlations: mental functioning (-0.47), social integration (-0.46), emotional regulation (-0.51), physical functioning (-0.48), and self-control (-0.41). A total of 33 patients (34%) were classified as depressed. Total SWN-K showed the highest AUC when discriminating between depressive severity levels (0.84), followed by emotional regulation (0.80), social integration (0.78), physical functioning and self-control (0.77), and mental functioning (0.73). Total SWN-K and its five subscales showed a significant linear trend against CDSS severity levels (P < 0.001). Conclusion: The presence of moderate to severe depressive symptoms was relatively high, and correlated inversely with patients' subjective well-being. Routine assessment of patient-reported measures in patients with schizophrenia might reduce potential discrepancy between patient and physician assessment, increase therapeutic alliance, and improve outcome.